- Home
- CTVA vs GEHC Comparison
CTVA vs GEHC Comparison
Compare CTVA & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTVA
- GEHC
- Stock Information
- Founded
- CTVA 2018
- GEHC 1892
- Country
- CTVA United States
- GEHC United States
- Employees
- CTVA N/A
- GEHC N/A
- Industry
- CTVA Farming/Seeds/Milling
- GEHC Computer Software: Prepackaged Software
- Sector
- CTVA Consumer Staples
- GEHC Technology
- Exchange
- CTVA Nasdaq
- GEHC Nasdaq
- Market Cap
- CTVA 44.9B
- GEHC 36.2B
- IPO Year
- CTVA N/A
- GEHC N/A
- Fundamental
- Price
- CTVA $62.79
- GEHC $91.09
- Analyst Decision
- CTVA Buy
- GEHC Buy
- Analyst Count
- CTVA 16
- GEHC 12
- Target Price
- CTVA $67.79
- GEHC $97.67
- AVG Volume (30 Days)
- CTVA 4.1M
- GEHC 2.8M
- Earning Date
- CTVA 02-05-2025
- GEHC 02-13-2025
- Dividend Yield
- CTVA 1.08%
- GEHC 0.15%
- EPS Growth
- CTVA 26.57
- GEHC 43.17
- EPS
- CTVA 1.30
- GEHC 4.34
- Revenue
- CTVA $16,908,000,000.00
- GEHC $19,672,000,000.00
- Revenue This Year
- CTVA $4.25
- GEHC $5.62
- Revenue Next Year
- CTVA $3.49
- GEHC $4.70
- P/E Ratio
- CTVA $51.44
- GEHC $20.99
- Revenue Growth
- CTVA N/A
- GEHC 0.61
- 52 Week Low
- CTVA $50.01
- GEHC $74.51
- 52 Week High
- CTVA $66.24
- GEHC $94.80
- Technical
- Relative Strength Index (RSI)
- CTVA 50.18
- GEHC 59.40
- Support Level
- CTVA $61.83
- GEHC $85.50
- Resistance Level
- CTVA $64.83
- GEHC $93.26
- Average True Range (ATR)
- CTVA 1.48
- GEHC 1.91
- MACD
- CTVA -0.22
- GEHC 0.20
- Stochastic Oscillator
- CTVA 37.45
- GEHC 60.11
About CTVA Corteva Inc.
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva operates globally, but around half of revenue comes from North America.
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%).